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Article / Clinical Case Report
ABSTRACT
Intestinal lipomatosis is rare and often asymptomatic but can present with intestinal obstruction. Occasionally, metastatic 
breast cancer is identified in the ovary before a breast primary is discovered. We report the case of a 50-year-old woman 
diagnosed with synchronous intestinal obstruction due to lipomatosis, and incidental ovarian metastases from breast 
cancer. The patient presented with a 12-day history of nausea, diffuse abdominal pain, and constipation. An abdominal 
x-ray showed air-fluid levels, and computed tomography documented small bowel distention. An explorative laparotomy 
was performed, which revealed small bowel distention, an obstructive lesion of the ileocecal valve, three terminal 
ileum lesions, ascites, and heterogeneous ovaries. Right ileocolic resection and left oophorectomy were performed. 
The pathological diagnosis revealed lipomatous submucosal lesion of the ileocecal valve and ileum, and 17 lymph nodes, 
which were all negative for malignant cells. The oophorectomy revealed ovarian metastasis from breast carcinoma. Ascitic 
fluid was positive for malignant cells. Mammography and breast/axillary ultrasonography showed a solid nodule of the 
left breast, ductal carcinoma, and multiple enlarged left axillary lymph nodes, which were positive for neoplastic cells. 
Immunohistochemical evaluation showed hormonal receptor positivity and C-erb2 negativity. Breast magnetic resonance 
imaging showed a 14 mm left nodule and a positron emission tomography scan revealed 18F-FDG uptake in the left 
breast, left axillary lymph nodes, right ovary, and peritoneum. The tumor was staged as stage IV ductal breast carcinoma, 
cT1N1M1, Grade 2, Luminal B-like. The multidisciplinary oncological meeting proposed chemotherapy, and a re-staging 
breast MRI after chemotherapy, which showed a complete response. The patient started treatment with letrozole and 
remains disease-free 22 months after finishing chemotherapy. 
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INTRODUCTION
Diffuse intestinal submucosal lipomatosis is 
a sporadic condition with a few cases reported 
in the medical literature.1 Usually, patients are 
asymptomatic, but these lesions may present as 
perforation, obstruction, ulceration, intussusceptions 
or bleeding.2,3
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Breast cancer is the most common malignancy in 
women worldwide, and is one of the leading causes 
of death among women,4 with a reported incidence 
rate of 46.3% and a mortality rate of 13%.5
Metastatic breast cancer to the ovaries is not 
uncommon and represents 6-27.8% of all malignant 
ovarian tumors; however, it has been reported at 
autopsies in 50% of patients with breast cancer.6,7
Here, we report the case of a woman with 
synchronous intestinal lipomatosis that presented as 
an intestinal obstruction, and was revealed to be an 
incidental diagnosis of breast cancer metastatic to 
the ovary.
CASE REPORT
A 50-year-old Caucasian woman presented to 
the emergency department with a 12-day history of 
nausea, diffuse abdominal pain, and constipation. 
She experienced menopause at the age of 42. 
Her past medical history included morbid obesity 
(BMI of 44 kg/m2), type 2 diabetes, arterial hypertension, 
hypercholesterolemia, and two cesarean sections. 
No relevant medical family history was informed. 
On physical examination, she presented a distended and 
tympanic abdomen, diffusely painful without guarding. 
The laboratory work-up showed a C-reactive protein of 
29.9 mg/L (normal range <7.5 mg/L) with 13.1 × 103/μL 
leukocytes (normal range 4.5-11.0 × 103/μL), and a 
plain abdominal x-ray documented air-fluid levels. 
Abdominal and pelvic contrast-enhanced computed 
tomography (CT) showed a minor small bowel 
distension without parietal enlargement, without 
a clear obstructive etiology, and with normal colon 
caliber.
Conservative therapeutic measures for intestinal 
obstruction were unsuccessful; therefore, she 
underwent a laparotomy within 24 hours of admission. 
Surgical findings included an entire small bowel 
distention, an obstructive lesion of the ileocecal 
valve with retracting serosa and mesentery, three 
terminal ileum implants resembling carcinomatosis, 
moderate ascites, and heterogeneous ovaries. 
Accordingly, ileocolic resection and left oophorectomy 
were performed. Ascitic fluid was sent for cytologic 
evaluation.
The post-operative period was uneventful; 
however, she was re-admitted 2 weeks after discharge 
due to wound infection, which resolved with antibiotics 
and dressings.
The pathological diagnosis revealed a lipomatous 
submucosal lesion of the ileocecal valve and terminal 
ileum, and all 17 sampled lymph nodes were negative 
for malignant cells. The oophorectomy identified 
an ovarian metastasis from breast carcinoma 
(Figures 1 and 2). Ascites cytology was positive for 
malignant cells, which were most likely from an 
adenocarcinoma.
The immunohistochemical evaluation revealed 
positivity for cytokeratin AE1/AE3, CK7 and hormonal 
Figure 1. Photomicrograph of the ovary. A – Ovarian parenchyma almost entirely occupied by a proliferation of 
malignant epithelioid cells arranged in small nests and cords (H&E, 200x); B – Tumor cells were large, with irregular 
nuclei and prominent nucleoli (H&E, 400x).
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receptors (HR) (75-100%), and negativity for CK20, 
e-cadherin, WT1, CA125, CDX2, and HER2 (score 0) 
(Figure 2).
A complementary study with mammography 
and ultrasonography of the breast and axilla was 
performed, which revealed a solid heterogeneous, 
spiculated nodule with 10 × 8 × 10 mm in the 
transition of the outer quadrants of the left breast, and 
multiple enlarged left axillary lymph nodes—the most 
prominent of which was 34 mm with metastatic 
features. Biopsies were performed, which revealed the 
presence of ductal carcinoma in the breast nodule. The 
fine-needle aspiration of the axillary lymph node was 
positive for neoplastic cells.
Histological findings were reviewed, and confirmed 
ovarian metastasis from ductal carcinoma of the breast. 
The immunohistochemical evaluation showed positivity 
for HR (75-100%), negativity for C-erb2 and Ki67 of 
15-30%.
The upper and lower endoscopies were negative.
A thoracic, abdominal and pelvic CT scan and an 
abdominal and pelvic magnetic resonance imaging 
(MRI) scan showed a 14 mm left breast nodule, multiple 
enlarged left axillary lymph nodes, a right normal ovary, 
and uterine fibromas.
A positron emission tomography (PET) scan 
revealed 18F-FDG uptake in the left breast, left 
axillary lymph nodes, right ovary, and peritoneum 
(Figures 3 and 4).
The baseline cancer antigen (CA)15.3 was 
76.17 U/mL (normal range < 30 U/mL).
The tumor was assessed as a stage IV ductal 
breast carcinoma, cT1N1M1 (ovarian and peritoneal 
metastasis), Grade 2, Luminal B-like (HR+, HER2−).
Figure 2. Photomicrograph of the ovary. Tumor cells showed immunoexpression of estrogen receptor (ER) in A, and 
progesterone receptor (PR) in B – intense staining in 75-100% cells, plus strong and diffuse immunoexpression of 
CK7 in C and gross cystic disease fluid protein (GCDFP-15) in D.
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Figure 3. PET scan showing 18F-FDG uptake in the left breast.
Figure 4. PET scan showing moderate 18F-FDG uptake in right ovary area and less uptake posteriorly and inferiorly, 
which could be peritoneal implants.
The patient was referred to an oncological 
center and evaluated in a multidisciplinary oncological 
meeting, which proposed palliative chemotherapy. 
The patient completed six cycles of doxorubicin and 
cyclophosphamide with good tolerance. The re-staged 
breast MRI and PET scan showed complete response, 
and CA15.3 had dropped to 17.81 U/m.
After re-evaluation by the multidisciplinary 
oncological meeting, the patient started hormonal 
treatment with letrozole, and now remains in complete 
remission 22 months after the end of chemotherapy.
DISCUSSION
Primary small intestinal tumors are uncommon, 
which account for about 1% of all gastrointestinal 
tumors, and primary lipomas of the small intestine 
are rare.8 The incidence rate of detection of intestinal 
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lipomatosis at autopsy ranges from 0.04% to 4.5%.2 
Lipomas of the intestine may be solitary, or multiple 
and encapsulated, or diffuse, discrete, non-capsulated 
lobules of adipose tissue, called lipomatosis. In 90% 
of the cases they are localized in the submucosa, but 
occasionally they extend into the muscularis propria, 
while up to 10% are subserosal.9
The colon is the most common site (65-75%) of 
lipoma location followed by the ileum.10 No predilection 
site has been mentioned for lipomatosis in the 
literature.11
The age of presentation is highly variable, 
ranging from the neonatal period to the seventh 
decade of life.3 No gender differences are observed.12 
Most intestinal lipomas are asymptomatic, but they 
can sometimes precipitate a surgical emergency, 
especially when the ileocecal valve and small intestine 
are affected.13 The most frequent presenting symptom 
is abdominal pain.14
The etiology of lipomatosis is yet to be established. 
Hypothetical etiological factors include embryonic 
displacement of adipose t issue; degenerative 
disease with disturbance of fat  metabol ism; 
post-chemotherapeutic fat deposition; chronic 
irritation, such as chronic inflammatory bowel disease; 
low-grade infection; and hamartomatous syndromes.15
Cl inical diagnosis may be diff icult,  but a 
pre-operative CT scan may be of value to characterize 
large submucosal masses, and to show the specific 
nature of a mass and the extent of disease.1
Plain abdominal films are non-specific and 
commonly demonstrate the presence of multiple 
air-fluid levels, which is suggestive of mechanical 
obstruction.1
The intraoperative appearance of the lesion can be 
confusing, and it may be difficult to exclude carcinoma 
on gross appraisal during surgery.1 This is similar to 
our case, which resembled ileocecal carcinoma or ileal 
carcinomatosis.
Ovarian metastases from breast cancer generally 
reflect advanced breast disease,4 and in most cases are 
bilateral.16 The challenge of diagnosing a malignancy 
metastatic to the ovary is that the clinicopathological 
characteristics vary and the morphology can be 
different from the corresponding primary tumor.17
In this case, metastatic breast cancer was identified 
in the ovary before the primary breast tumor was 
suspected. The primary neoplasm may be quite 
small, and detailed imaging may be necessary for its 
detection.18 Lobular carcinomas are known to spread to 
the ovary more frequently than ductal carcinomas, but 
because ductal cancer is considerably more common, 
most diagnostic challenges are posed by tumors with 
a ductal morphology.7
Metastatic involvement of the peritoneum in 
the setting of breast cancer is rare.19 Therefore, it is 
mandatory to exclude other primary tumors, such as 
gastric and colorectal cancer, which more frequently 
present with peritoneal carcinomatosis. In this case, 
other etiologies were excluded with endoscopic 
studies, CT, MRI, and PET scans.
Patients with metastatic breast cancer are unlikely 
to be cured of their disease with any treatment.20
The removal of the primary tumor in patients with 
stage IV breast cancer has not been associated with 
prolongation of survival, with the possible exception 
of bone-only disease, being considered only in selected 
patients to improve quality of life.20 Deviations to this 
approach may be made on a case-by-case basis in a 
multidisciplinary setting, although these instances are 
exceptional.
Complete remissions from systemic chemotherapy 
are uncommon, and, indeed, only a small fraction 
of complete responders remain progression-free 
for a prolonged period (being mostly those with 
oligometastatic disease or low-volume metastatic 
disease).20 The patient reported herein started 
chemotherapy and experienced a substantial response. 
However, such tumors expressing hormonal receptors 
should start with hormonal/endocrine therapy, even 
in cases of visceral disease. Chemotherapy should be 
reserved for non-responders or for patients with a high 
tumor burden, or whenever rapid disease/symptoms 
control (e.g. a visceral crisis) is needed.20 Furthermore, 
even in patients who progress after first-line endocrine 
therapy, there are now targeted agents (e.g. the 
CDK4/6 inhibitors), which can be added to endocrine 
therapy, with good long-term survival results.20
The median survival for patients with stage IV 
breast cancer is 18-24 months, although the range 
extends from only a few months to many years.21
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CONCLUSION
Intestinal lipomatosis is rare and frequently 
asymptomatic, but occasionally it can present as an 
intestinal obstruction and should be kept as a differential 
diagnosis in unusual cases. Pre-operative image 
findings and even intra-operative macroscopic findings 
can be misleading; therefore, histologic evaluation will 
confirm the diagnosis. Ovarian metastasis eventually 
can be an incidental finding and be identified before 
the primary breast tumor. Metastatic involvement of 
the peritoneum in breast cancer patients is rare; thus, 
it is important to exclude other primary tumors. Stage 
IV breast cancer should be managed with endocrine 
therapy, targeted therapy and/or chemotherapy, 
depending on the hormonal receptors and the C-erb2 
status, plus the patient’s comorbidities, performance 
status, response to previous treatments, tumor burden, 
and associated symptoms. Our patient presented a rare 
cause of intestinal obstruction, a not-so-common case 
of ovarian and peritoneal carcinomatosis from breast 
cancer, and a rare case of complete response after 
chemotherapy in stage IV luminal breast cancer.
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